ProteinQure founding team (from L-R): Chief R&D Officer Mark Fingerhuth, CSO Chris Ing, CEO Lucas Siow and Chief Technical Officer Tomas Babej

May 27, 2025 07:00 AM EDT

Exclusive: Toronto biotech ProteinQure nears the clinic with peptide platform as it raises $11M Series A

Andrew Dunn

Senior Biopharma Correspondent

When Lucas Siow and his three fellow co-founders started ProteinQure in 2017, they had nine years of combined work experience, and Siow accounted for seven …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Exclusive: Toronto biotech ProteinQure nears the clinic with peptide platform as it raises $11M Series A

Andrew Dunn

Senior Biopharma Correspondent

Sign up to read this article for free.

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

A new dawn for psychedelics? Compass could be the first to find out

Weeks after TIGIT fail, iTeos decides to wind down

Updated: MD Anderson-allied investment firm targets $250M for second cancer biotech fund

The fate of Moderna’s next-gen Covid shot looms large after a flurry of policy changes

GSK, Spero report Phase 3 win for UTI antibiotic; Spero's stock soars

From weeks to days: how Aizon Intelligent Agents transform pharma validation

Ex­clu­sive: Toron­to biotech Pro­tein­Qure nears the clin­ic with pep­tide plat­form as it rais­es $11M Se­ries A

Senior Biopharma Correspondent

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Exclusive: Toronto biotech ProteinQure nears the clinic with peptide platform as it raises $11M Series A